Cs Diagnostics CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OTC.Pink
Antonio Santoli has disclosed a 9.9% beneficial ownership stake in CS Diagnostics Corp., primarily through common and convertible Series B Preferred Stock.
OTC.Pink
Thomas Graus has reported a 9.9% beneficial ownership stake in CS DIAGNOSTICS CORP., comprising common stock and convertible Series B Preferred Stock.